Skip to main content
Equibles

Persistent Asset Partners Ltd

Position in VTGN — Vistagen Therapeutics, Inc.

CIK 2056052 HONG KONG, K3
Back to VTGN Full portfolio

Position in VTGN

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$0
-$15,168 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
7 quarters on record

Common Shares in VTGN Over Time

Shares Held

Position Value (USD)

Derivatives in VTGN

reported options exposure · as of Jun 30, 2026
CallValue
$33
CallShares
147
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Persistent Asset Partners Ltd holds $74,585,923 across 142 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 38,726 $7,252,604
2 ABVX
Abivax S.A.
 44,256 $5,897,553
3 COGT
Cogent Biosciences, Inc.
 138,272 $5,351,125
4 BMRN
Biomarin Pharmaceutical Inc
 79,933 $4,573,766
5 VKTX
Viking Therapeutics, Inc.
 112,736 $4,397,831
6 EWTX
Edgewise Therapeutics, Inc.
 69,441 $2,821,387
7 KOD
Kodiak Sciences Inc.
 56,052 $2,183,785
8 IMCR
Immunocore Holdings plc
 65,214 $2,070,544

All Filings in VTGN

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $33 147
2026-03-31 $15,168 26,612
2025-12-31 $17,563 26,612
2025-09-30 $267,382 75,319
2025-06-30 $173,638 86,819
2025-03-31 $304,127 121,651
2024-12-31 $358,870 121,651